Business
Bio Spectrum
Karnataka unveils Rs 600+ Cr 'Deep Tech Decade' initiative
The Government of Karnataka has announced an investment of over Rs 600 crore to power the state's \"Deep Tech Decade,\" with the goal of establishing Karnataka as the Deep Tech Capital of India.
1 min |
December 2025
Bio Spectrum
Revvity and Profluent bring AI-enhanced adenine deaminase pin-point base editing systems
US-based Revvity, Inc. has announced a strategic collaboration with Profluent, also based in the US, bringing together a range of its novel artificial intelligence (AI)engineered enzymes with Revvity's established Pin-point base editing platform.
1 min |
December 2025
Bio Spectrum
Agilent introduces Altura Line of Inert HPLC columns for biotherapeutic testing
Agilent Technologies Inc. has announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications.
1 min |
December 2025
Bio Spectrum
Bartronics India makes strategic investment of up to Rs 50 Cr in Huwel Life Sciences
Hyderabad-based Bartronics India Limited (BIL), a listed technology and services company, has announced a strategic investment of up to Rs 50 crore in Huwel Life Sciences, a molecular diagnostics startup, also based in Hyderabad.
1 min |
December 2025
Bio Spectrum
Qure.ai launches world's first AI-powered paediatric TB screening tool
Diagnosing tuberculosis (TB) in children has long been a challenge, but that is set to change. qXR from Mumbai-based startup Qure.ai is the first AI-enabled chest X-ray tool to receive regulatory clearance, earning CE Class IIb certification for children aged 0-3 years and complementing its existing capabilities for children up to 15 years, effectively covering the entire childhood spectrum.
1 min |
December 2025
Bio Spectrum
Bessemer Venture Partners leads Rs 125 Cr Series A funding in fertility startup Pluro
Pluro Fertility and IVF, a healthcare partnership platform, has raised Rs 125 crore in Series A funding round led by Bessemer Venture Partners at a valuation of Rs 1,000 crore.
1 min |
December 2025
Bio Spectrum
Helex raises $3.5 M to advance targeted gene therapies for kidney diseases
Helex, a US and India-based therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, has announced its oversubscribed $3.5 million Seed round, led by pi Ventures.
1 min |
December 2025
Bio Spectrum
Alkem Foundation and IIT-B to set up advanced research centre for immuno- therapeutics and regenerative medicines
Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Mumbai-based Alkem Laboratories, and Indian Institute of Technology Bombay (IIT-B) have announced a strategic collaboration to set up a first- of-its-kind research centre in India dedicated to immuno- therapeutics and regenerative medicines.
1 min |
December 2025
Bio Spectrum
DPIIT signs MoU with Primus Partners to strengthen startup ecosystem
The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MoU) with Primus Partners to enhance collaboration towards strengthening India's startup and innovation ecosystem.
1 min |
December 2025
Bio Spectrum
MedGenome makes majority investment in Gujarat's Green Cross
Bengaluru-based MedGenome, a leading global genomics-driven diagnostics and research services company, has announced a majority investment in Gujarat-headquartered pathology laboratory chain, Green Cross Genetics Lab.
1 min |
December 2025
Bio Spectrum
ANRF, in collaboration with ICMR and Gates Foundation, launches Maha MedTech Mission
Anusandhan National Research Foundation (ANRF), in collaboration with the Indian Council of Medical Research (ICMR) and the Gates Foundation, has launched the Mission for Advancement in High-Impact Areas (MAHA)-Medical Technology (hm MedTech).
1 min |
December 2025
Bio Spectrum
Re-Pivoting Pharma Strategy
The United States has effectively shut the door on several Indian medicines after President Donald Trump imposed a steep 100 per cent duty on branded and patented drugs. The tariff, effective from October 1, triggered trade and policy uncertainty across the global pharmaceutical industry. Till then, medicines had largely been spared from the Trump administration's tariff regime. The abrupt move forced drug exporters to the US to rethink their strategies. India, however, remained insulated to some extent because of the nature of its export basket and presence of manufacturing units of some Indian companies in the US.
2 min |
December 2025
Bio Spectrum
Breaking Ground in Clinical Trials: India's Innovation Imperative
For decades, India has been a global powerhouse in pharmaceutical manufacturing. Yet in clinical trials, the crucial bridge between laboratory discoveries and patient access, the country’s performance has lagged behind its industrial capabilities.
5 min |
November 2025
Bio Spectrum
MOFs for Next-Gen Therapies
Susumu Kitagawa, Richard Robson and Omar M Yaghi have been awarded the Nobel Prize in Chemistry 2025 for the development of a new type of molecular architecture called metal-organic frameworks (MOFs), opening new avenues for applications such as drug delivery, biomedical imaging and personalised medicine.
2 min |
November 2025
Bio Spectrum
We aim to make bio-based industries a key pillar of the state's GSDP by 2030: Kerala CM
Kerala recently set the spotlight on its growing life sciences ecosystem with Bio Connect 3.0 – International Life Sciences Conclave & Expo, held on October 9 & 10, 2025, in Thiruvananthapuram. The event brought together global innovators, researchers, investors, and industry leaders to explore opportunities, collaborations, and advancements across biotechnology, healthcare, digital health, and allied sectors. Organised by the Kerala Life Sciences Industries Park (KLIP) and the Kerala State Industrial Development Corporation (KSIDC), this conclave featured thought-provoking discussions, visionary keynote sessions, and cutting-edge technology showcases.
3 min |
November 2025
Bio Spectrum
The AI Job Loss Threat Conundrum
There are assumptions that Artificial Intelligence (AI) will take away pharma and healthcare jobs. But many are of the opinion that AI will help to transform jobs as well as create new ones in the long run. How much pharma and healthcare companies invest in AI and cope with the latest AI innovations will determine who can survive and who will perish. Let's find out.
5 min |
November 2025
Bio Spectrum
Molbio announces collaboration with UE LifeSciences to expand iBreastExam globally
Molbio Diagnostics, a Goa-based point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies, and UE LifeSciences, a Philadelphia-based innovator engaged in the business of developing and manufacturing health technology solutions, with a primary focus on enabling early cancer detection technologies, have announced an exclusive collaboration, seeking to make early breast cancer detection accessible to millions of women in over 50 countries across the developing world.
1 min |
November 2025
Bio Spectrum
CRO Reforms: Tilting Scale towards Accelerated Growth & Transparency
India's clinical research ecosystem is undergoing a major transformation, driven by a wave of regulatory reforms and rapid market expansion.
10 min |
November 2025
Bio Spectrum
When Spectra Speak: Letting AI Read the Fine Print of Biologics
Biologic characterisation has historically relied heavily on spectroscopy, which transforms chemical complexity into comprehensible fingerprints. Through the careful use of AI, supported by strict data procedures and scientific supervision, these fingerprints may be read more quickly & thoroughly.
5 min |
November 2025
Bio Spectrum
Working on our supply chain to set benchmarks in quality and further enhance India's position as a trusted clinical research supplier on a global scale
Abdos Lifesciences, which is committed to enabling science to thrive by delivering precision-engineered, high-performance laboratory consumables and instruments that meet the highest global standards, manufactures over 400 products across 12+ categories in automated cleanroom environments certified under ISO and CE-IVDR standards, ensuring sterility, traceability, and consistency crucial for decentralised and global clinical trials. Each product is barcoded, tamper-proof, and supported by easily accessible documentation such as Certificates of Analysis (COA), Technical Data Sheets (TDS). With a presence in more than 90 countries, Abdos Lifesciences ensures researchers worldwide receive reliable products and dedicated support, empowering science to advance seamlessly across borders and timelines. In an interview with BioSpectrum India Shrey Agarwal, CEO & Director, Abdos Lifesciences spoke to many issues including how the company is ensuring compliance with evolving global standards for products used in regulated clinical environments. Edited excerpts;
4 min |
November 2025
Bio Spectrum
Gene Solutions and AMPATH launch advanced genomics laboratory in Hyderabad
Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad.
1 min |
November 2025
Bio Spectrum
Patient Consent - How is it different under medical ethics and data protection?
In the ethical and legal framework of medicine and law, consent has always existed. Within healthcare, it signifies the individual's right to be informed and to choose. However, in the digital era, consent assumes a broader function; it becomes the foundation for lawful processing of personal data. For the pharma and clinical-research sectors, this distinction carries significant implications. The Digital Personal Data Protection Act, 2023 (DPDPA), has redefined how personal and health-related data must be managed. This article explores why consent under data-protection law differs from medical consent, drawing lessons from the irregularities uncovered in the Ahmedabad clinical trials, and outlines the emerging compliance responsibilities under the DPDPA.
3 min |
November 2025
Bio Spectrum
DBT inks pact with Uttar Pradesh to boost biotech, pharma and medtech innovation
An official Memorandum of Understanding (MoU) has been signed between the Department of Biotechnology (DBT), Government of India and the Government of Uttar Pradesh.
1 min |
November 2025
Bio Spectrum
Abbott launches world's first dual-chamber leadless pacemaker system in India
Abbott, a global healthcare company, has announced the launch of AVEIR dual chamber (DR) leadless pacemaker system - the first of its kind in the world.
1 min |
November 2025
Bio Spectrum
Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr
Delhi-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).
1 min |
November 2025
Bio Spectrum
Alkem Foundation invests Rs 100 Cr towards opening radiotherapy centre in Bihar
Alkem Foundation, a wholly owned subsidiary and CSR arm of Alkem Laboratories Ltd., has supported the establishment of Samprada Singh Memorial Radiotherapy Centre in Muzaffarpur, Bihar, with an investment of Rs 100 crore.
1 min |
November 2025
Bio Spectrum
Gaudium IVF and Women Health re-files DRHP with SEBI
Delhi-based Gaudium IVF and Women Health has refiled its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI).
1 min |
November 2025
Bio Spectrum
Ayush Ministry launches Integrative Oncology Research and Care Centre
The Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda (AIIA), Dhargal, Goa.
1 min |
November 2025
Bio Spectrum
Medtronic unveils two advanced surgical energy generators in India
Medtronic, a global leader in healthcare technology, has announced the launch of two advanced surgical energy generators in India under the Valleylab FT10 series - the Valleylab FT10 Electrosurgical Generator (VLFT10FXGEN) and the Valleylab FT10 Vessel Sealing Generator (VLFT10LSGEN).
1 min |
November 2025
Bio Spectrum
Cabinet approves DSIR Scheme of Capacity Building and HR Development with outlay of Rs 2277 Cr
The Cabinet, chaired by the Prime Minister Narendra Modi, has approved the Department of Scientific and Industrial Research Council of Scientific and Industrial Research (DSIR/CSIR) Scheme on \"Capacity Building and Human Resource (HR) Development\" with a total outlay of Rs 2277.397 crore for the period of the Fifteenth Finance Commission Cycle 2021-22 to 2025-26.
1 min |